XML 49 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended 15 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Restricted Shares
Mar. 31, 2013
Restricted Shares
Jun. 30, 2013
Stock Options
Mar. 31, 2013
Stock Options
Jun. 30, 2012
Stock Options
Jun. 30, 2013
Stock Options
Jun. 30, 2012
Stock Options
Dec. 31, 2012
Stock Options
Jun. 30, 2013
2009 Option Plan
Jun. 30, 2013
2000 Option Plan and 2009 Option Plan
Jun. 30, 2013
Directors Option Plan
Jun. 30, 2013
Directors Restricted Stock Plan
Jun. 30, 2013
2000 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award                                  
Number of additional options that can be granted                                 0
Shares available for the granting of additional stock options                         2,328,940   70,000 95,131  
Options ratable vesting period                           5 years 3 years    
Options exercisable period                           10 years 10 years    
Number of additional options expected to be granted                             0    
Expense incurred for stock-based compensation plans (in dollars) $ 8,890 $ 7,610 $ 17,175 $ 15,101                          
Expense incurred for stock-based compensation plans, net of tax (in dollars) 6,473 5,498 12,503 10,851                          
Stock option activity                                  
Options outstanding at the beginning of the period (in shares)             12,344,775 13,446,719   13,446,719              
Options granted (in shares)             2,742,150                    
Options exercised (in shares)             (843,615) (1,043,444)                  
Options forfeited (in shares)             (44,720) (58,500)                  
Options outstanding at the end of the period (in shares)             14,198,590 12,344,775   14,198,590   13,446,719          
Vested and non-vested expected to vest at the end of the period (in shares)             12,806,480     12,806,480              
Exercisable at the end of the period (in shares)             6,143,659     6,143,659              
Weighted Average Exercise Price                                  
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share)             $ 44.37 $ 43.39   $ 43.39              
Weighted average exercise price, options granted (in dollars per share)             $ 78.00                    
Weighted average exercise price, options exercised (in dollars per share)             $ 38.03 $ 31.30                  
Weighted average exercise price, options forfeited (in dollars per share)             $ 48.69 $ 50.58                  
Weighted average exercise price, options outstanding at the end of the period (in dollars per share)             $ 51.23 $ 44.37   $ 51.23   $ 43.39          
Weighted average exercise price, vested and non-vested expected to vest (in dollars per share)             $ 50.64     $ 50.64              
Weighted average exercise price, exercisable (in dollars per share)             $ 41.17     $ 41.17              
Weighted Average Remaining Contractual Term                                  
Weighted average remaining contractual term of options outstanding             7 years 5 months 26 days 7 years 22 days       7 years 29 days          
Weighted average remaining contractual term of options vested and non-vested expected to vest             7 years 4 months 24 days                    
Weighted average remaining contractual term of options exercisable             6 years 14 days                    
Aggregate Intrinsic Value                                  
Aggregate intrinsic value of options outstanding (in dollars)             379,390 373,596   379,390   268,596          
Aggregate intrinsic value of options, vested and non-vested expected to vest (in dollars)             349,739     349,739              
Aggregate intrinsic value of options exercisable (in dollars)             225,898     225,898              
Status of the Company's non-vested options and changes during the year                                  
Non-vested options at the beginning of the period (in shares)             7,884,057 7,951,177   7,951,177              
Non-vested options, options granted (in shares)             2,742,150                    
Non-vested options, options vested (in shares)             (2,526,556) (8,620)                  
Non-vested options, options forfeited (in shares)             (44,720) (58,500)                  
Non-vested options at the end of the period (in shares)             8,054,931 7,884,057   8,054,931   7,951,177          
Weighted Average Fair Value at Grant Date                                  
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share)             $ 13.35 $ 13.36   $ 13.36              
Weighted average fair value at grant date, options granted (in dollars per share)             $ 17.41                    
Weighted average fair value at grant date, options vested (in dollars per share)             $ 13.32 $ 15.62                  
Weighted average fair value at grant date, options forfeited (in dollars per share)             $ 13.40 $ 13.50                  
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share)             $ 14.75 $ 13.35   $ 14.75   $ 13.36          
Total intrinsic value of stock options exercised (in dollars)             34,093   16,118 74,635 40,937            
Total fair value of stock options vested (in dollars)             33,647   30,763 33,781 30,882            
Total compensation cost related to non-vested options not yet recognized (in dollars)             100,520     100,520              
Weighted average expected amortization period         10 months 24 days         3 years 8 months 12 days              
Number of restricted shares issued         12,824 17,045                      
Weighted-average grant date fair value of restricted shares (in dollars per share)         $ 78.00 $ 53.78                      
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars)         $ 896